Product Information
CLINDAMYCIN HCL 75 MG CAPSULE is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.2587 per EA under NDC 68462014201. Its NADAC has been published 153 times since Jun 7, 2023.
FDA first approved this application on Mar 10, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
75 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462014201
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CLINDAMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA216957FDA Approved
3/10/2023
TE Code
AB
On Market Since
3/10/2023
Pharmacological Classes
Price Statistics
The NADAC for CLINDAMYCIN HCL 75 MG CAPSULE has been published 153 times since Jun 7, 2023, and over the history we have for it it has declined 21.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2587 per EA |
|---|---|
| All-time high | $0.3314 (Aug 13, 2025) |
| All-time low | $0.2389 (Aug 21, 2024) |
| 52-week high | $0.3143 |
| 52-week low | $0.2508 |
| Median price | $0.2908 |
| Average price | $0.2911 |
| Largest weekly change | -11.9% (May 22, 2024) |
| Weeks tracked | 153 |
| Tracking since | Jun 7, 2023 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clindamycin Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Lincosamide Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLINDAMYCIN HCL 75 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CLINDAMYCIN HCL 75 MG CAPSULE, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.2587 per EA (NDC 68462014201), effective Sep 30, 2026.
How has the price of CLINDAMYCIN HCL 75 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CLINDAMYCIN HCL 75 MG CAPSULE has declined 21.4%. It has been tracked across 153 weekly CMS publications since Jun 7, 2023.
What are the highest and lowest recorded NADAC prices for CLINDAMYCIN HCL 75 MG CAPSULE?
Since Jun 7, 2023, the NADAC for CLINDAMYCIN HCL 75 MG CAPSULE has ranged from a low of $0.2389 (Aug 21, 2024) to a high of $0.3314 (Aug 13, 2025), with a median of $0.2908 per EA.
Are there cheaper alternatives to CLINDAMYCIN HCL 75 MG CAPSULE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CLINDAMYCIN HCL 75 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures CLINDAMYCIN HCL 75 MG CAPSULE?
CLINDAMYCIN HCL 75 MG CAPSULE (NDC 68462014201) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.